Slc6a5 | solute carrier family 6 (neurotransmitter transporter, glycine), member 5
Physiological systems
22 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Hematopoietic system Skeleton Mortality/aging
19 No significant impact
2 Not tested
Gene metrics:4Significant phenotypes
2Associated diseases
Expression examined in:73Adult tissues
50Embryo tissues
preweaning lethality, complete penetrance | 3 supporting datasets | Slc6a5tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
abnormal lumbar vertebrae morphology | 1 supporting dataset | Slc6a5tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.27x10-8 | ||
increased mean corpuscular hemoglobin concentration | 1 supporting dataset | Slc6a5tm1.1(KOMP)Vlcg | heterozygote | Early adult | 8.33x10-6 | ||
abnormal sacral vertebrae morphology | 1 supporting dataset | Slc6a5tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.27x10-8 |
| | | | | | | | | |
External links
No external links available for Slc6a5.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.